OS-079-YI Hemodynamic and non-hemodynamic effects of non-selective beta-blockers in experimental and human acute-on-chronic liver failure
Vlad Țâru(Iuliu Hațieganu University of Medicine and Pharmacy), Benedikt Simbrunner(Austrian Academy of Sciences), Katharina Bonitz(Austrian Academy of Sciences), Thomas Reiberger(ERN GUARD-Heart), Benedikt Hofer(Austrian Academy of Sciences), Thomas Sorz‐Nechay(Austrian Academy of Sciences), Henriette Horstmeier(Medical University of Vienna), Philipp Schwabl(Austrian Academy of Sciences), Georg Kramer(Medical University of Vienna), Mattias Mandorfer(Medical University of Vienna), Kerstin Zinober(Medical University of Vienna), Bogdan Procopeț(Iuliu Hațieganu University of Medicine and Pharmacy)
Cited by 0
Related Papers
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score
|Journal of Hepatology|2021|309
Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammation
|Journal of Hepatology|2024|239
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality
|Journal of Hepatology|2020|202
Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Cirrhosis
|Clinical Gastroenterology and Hepatology|2022|130
An orthotopic mouse model of hepatocellular carcinoma with underlying liver cirrhosis
|Nature Protocols|2015|119